Literature DB >> 22291781

Solid variant of serous cystadenoma of the pancreas.

Akira Yasuda1, Hirozumi Sawai, Nobuo Ochi, Yoichi Matsuo, Yuji Okada, Hiromitsu Takeyama.   

Abstract

We describe a case of a solid variant of serous cystadenoma of the pancreas. The preoperative examination results led to a diagnosis of a nonfunctional pancreatic islet cell tumour, and the patient underwent a pylorus-preserving pancreaticoduodenectomy. The tumour was diagnosed as a solid variant of serous cystadenoma by histopathological examination. Solid variant of serous cystadenoma of the pancreas is difficult to diagnose preoperatively. More cases must be accumulated and investigated to obtain clues for accurate diagnosis.

Entities:  

Keywords:  pancreas; pancreatic tumour; solid serous cystadenoma

Year:  2011        PMID: 22291781      PMCID: PMC3258726          DOI: 10.5114/aoms.2011.22092

Source DB:  PubMed          Journal:  Arch Med Sci        ISSN: 1734-1922            Impact factor:   3.318


Introduction

The solid variant of serous cystadenoma (SC) was first described by Perez-Ordonez in 1994 [1], and the tumour was defined as a solid tumour with cytological features of serous microcystic adenoma. Because solid variant SC is very rare, it is difficult to diagnose preoperatively. Magnetic resonance imaging (MRI) was reported to be useful for accurate diagnosis [2], but a definite consensus has not been reached. Here, we present our patient and review previous cases.

Case report

A 72-year-old woman was found to have a 2 cm tumour in the pancreatic head based on an ultrasound examination. Unenhanced computed tomography (CT) demonstrated a 2 cm low-density tumour in the pancreatic head (Figure 1A). It was strongly enhanced in the early phase of contrast-enhanced CT (Figure 1B), and the enhanced effect was prolonged to the late phase (Figure 1C). With MRI, it displayed a high intensity on the T2-weighted image (Figure 2). When we inspected the tumour using endoscopic ultrasonography (EUS), no cyst was recognized. Serum concentrations of glucagon and gastrin were normal. Therefore, we suspected a non-functional pancreatic islet cell tumour and performed a pylorus-preserving pancreaticoduodenectomy (PPPD). In the resected specimen, the tumour appeared clearly demarcated and solid, and it was 1.7 × 1.3 cm in size. No cyst was recognizable with the naked eye (Figure 3). The tumour had histopathological features of SC (Figure 4). There was no evidence of malignancy. The final diagnosis was solid variant of SC of the pancreas. Written consent was obtained from the patient for publication of the study according to guidelines of the ethical committee of the Nagoya City University Hospital.
Figure 1

Unenhanced CT demonstrated a low-density tumour of 2 cm in the area between the pancreatic head and the second portion of the duodenum (A). The tumour was strongly enhanced in the early phase of contrast-enhanced CT (B), and the enhanced effect was prolonged to the late phase (C)

Figure 2

The tumour displayed a high intensity on the T2-weighted MRI image

Figure 3

The tumour existed in the pancreatic head. It appeared clearly demarcated and solid, and it was 1.7 × 1.3 cm in size. No cyst was recognized with the naked eye

Figure 4

Histopathological examination of the tumour (haematoxylin/eosin stain). (A) Low magni - fication (×40) and (B) high magnification (×200). Histopathological examination demonstrated that the tumour was surrounded by a wall, like a capsule, and was composed of a large number of small cysts. The walls of the cysts were cubic cells that had a small, round nucleus and pale-coloured cytoplasm. There was no evidence of malignancy

Discussion

Solid variant of SC is very rare; only eight cases, including our case, have been reported (Table I) [1-7]. As with the other pancreatic tumours, it is very difficult to make an accurate diagnosis of SC [8-1], because there are no characteristic symptoms; the identified cases were accompanied by non-specific abdominal pain or were discovered during examinations for other diseases. Distal pancreatomy or PPPD was performed based on tumour location, except for one enucleation. Solid variant of SC is difficult to diagnose preoperatively, and the tumour was diagnosed as an islet cell tumour in most of the previous cases. We also diagnosed the tumour preoperatively as a non-functional islet cell tumour because it was strongly enhanced on contrast-enhanced CT, and no cystic lesion was observed. In the previous cases, the enhancing effect on CT was characteristic of solid serous adenoma, but this feature is also recognized in islet cell tumours and acinar cell tumours; therefore, it is not a definitive clue for diagnosis. Solid variant of SC was proposed as a preoperative diagnosis in only one previous case [2], in which it was reported that MR cholangiopancreatography (MRCP) was useful for diagnosis. The signal intensity of the pancreatic tumour remained higher than that of the cavernous haemangioma and equal to that of the hepatic cyst, which were detected incidentally on MRCP, and the investigators considered that the tumour was not a solid tumour, but a purely cystic tumour. According to these views, a solid type of SC was suspected. Magnetic resonance imaging was performed in our case as well, but no haemangioma or cyst was observed in the liver, so we could not observe the findings. Magnetic resonance imaging was not performed for the other 6 cases. We diagnosed the tumour preoperatively as a non-functional islet cell tumour and performed PPPD because approximately two-thirds of non-functional pancreatic islet cell tumours are malignant. However, a less invasive intervention, such as partial pancreatomy or observation without surgery, can be selected if the tumour is diagnosed accurately.
Table I

Eight cases of solid variant of serous cystadenoma

AgeSexSymptomPreoperative diagnosisLocationSize [cm]CT (U/E)MRI (T1/T2)Operation
70FAbd. painPancreatic islet tumourBody4.0--DP
50MAbd. painPancreatic islet tumourHead2.5--Unknown
58FNonePancreatic islet tumourBody2.0-/High-DP
59FAbd. painSolid SCBody2.0Low/HighLow/HighDP
66MNonePancreatic islet tumourHead4.0-/High-PPPD
74MNonePancreatic islet tumourBody1.6-/High-Enucleation
62MAbd. painPancreatic islet tumourBody4.2-/High-DP
72FNonePancreatic islet tumourHead1.7Low/High-/HighPPPD

Abd. pain - abdominal pain, SC - serous cystadenoma, CT (U/E) - CT (unenhanced/enhanced), PPPD - pylorus preserved pancreaticoduodenectomy, DP - distal pancreatomy

In conclusion, we encountered a rare pancreatic tumour, solid variant of SC, but it was difficult to diagnose preoperatively. Accurate diagnosis is important for deciding the surgical method, so more cases must be accumulated and investigated to obtain clues for accurate diagnosis.
  9 in total

1.  Solid serous adenoma of the pancreas: a solid variant of serous cystadenoma or a separate disease entity?

Authors:  Masahiko Yamaguchi
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

2.  Solid serous adenoma of the pancreas: a rare form of serous cystadenoma.

Authors:  Madhusudhan R Sanaka; Thomas E Kowalski; Corey Brotz; Charles J Yeo; Peter McCue; Juan Palazzo
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

3.  Solid serous cystadenoma of the pancreas: MR imaging with pathologic correlation.

Authors:  T Gabata; N Terayama; M Yamashiro; S Takamatsu; K Yoshida; O Matsui; M Usukura; M Takeshita; H Minato
Journal:  Abdom Imaging       Date:  2005-02-07

4.  Solid serous adenoma of the pancreas: a rare variant within the family of pancreatic serous cystic neoplasms.

Authors:  Stephen A Reese; L William Traverso; Timothy W Jacobs; Daniel S Longnecker
Journal:  Pancreas       Date:  2006-07       Impact factor: 3.327

5.  Solid serous adenoma of the pancreas. The solid variant of serous cystadenoma?

Authors:  B Perez-Ordonez; A Naseem; P H Lieberman; D S Klimstra
Journal:  Am J Surg Pathol       Date:  1996-11       Impact factor: 6.394

6.  Palliative first-line treatment with weekly high-dose 5-fluorouracil as 24h-infusion and gemcitabine in metastatic pancreatic cancer (UICC IV).

Authors:  Sandra Roehrig; Axel Wein; Heinz Albrecht; Peter C Konturek; Udo Reulbach; Gudrun Männlein; Kerstin Wolff; Nicola Ostermeier; Werner Hohenberger; Eckhart G Hahn; Frank Boxberger
Journal:  Med Sci Monit       Date:  2010-03

7.  Serous cystic neoplasms of the pancreas: an immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers.

Authors:  Markus Kosmahl; Janning Wagner; Katharina Peters; Bence Sipos; Günter Klöppel
Journal:  Am J Surg Pathol       Date:  2004-03       Impact factor: 6.394

8.  Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.

Authors:  Constantinos Giaginis; Eleftheria Katsamangou; Gerasimos Tsourouflis; Diamanto Zizi-Serbetzoglou; Gregorios Kouraklis; Stamatios Theocharis
Journal:  Med Sci Monit       Date:  2009-05

9.  Solid serous microcystic adenoma of the pancreas.

Authors:  Jordan R Stern; Wendy L Frankel; E Christopher Ellison; Mark Bloomston
Journal:  World J Surg Oncol       Date:  2007-03-05       Impact factor: 2.754

  9 in total
  11 in total

Review 1.  Solid Serous Adenoma of Pancreas, Misdiagnosed as Neuroendocrine Tumor, a Rare Case Report and Review of the Literature.

Authors:  Bita Geramizadeh; Mohammad-Hossein Dabbaghmanesh; Saman Nikeghbalian; Neda Soleimani
Journal:  J Gastrointest Cancer       Date:  2016-12

Review 2.  [Classification and malignant potential of pancreatic cystic tumors].

Authors:  I Esposito; A M Schlitter; B Sipos; G Klöppel
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

Review 3.  Benign Tumors and Tumorlike Lesions of the Pancreas.

Authors:  Olca Basturk; Gokce Askan
Journal:  Surg Pathol Clin       Date:  2016-12

Review 4.  Transabdominal ultrasonographic diagnosis of relatively rare pancreatic neoplasms.

Authors:  Senju Hashimoto; Kazunori Nakaoka; Hiroyuki Tanaka; Teiji Kuzuya; Naoto Kawabe; Mitsuo Nagasaka; Yoshihito Nakagawa; Ryoji Miyahara; Tomoyuki Shibata; Yoshiki Hirooka
Journal:  J Med Ultrason (2001)       Date:  2022-02-12       Impact factor: 1.314

5.  Microcystic serous cystadenoma mimicking pancreatic neuroendocrine neoplasm: report of a resected case with preoperative diagnostic difficulty and review of the literature.

Authors:  Shinichiro Nakamura; Katsunori Uchida; Yasuhiro Murata; Kenichiro Nishikawa; Yusuke Iizawa; Takehiro Fujii; Akihiro Tanemura; Naohisa Kuriyama; Masashi Kishiwada; Shugo Mizuno
Journal:  Surg Case Rep       Date:  2022-09-30

6.  Hypervascular solid-appearing serous cystic neoplasms of the pancreas: Differential diagnosis with neuroendocrine tumours.

Authors:  Hye Sun Park; So Yeon Kim; Seung-Mo Hong; Seong Ho Park; Seung Soo Lee; Jae Ho Byun; Jin Hee Kim; Hyoung Jung Kim; Moon-Gyu Lee
Journal:  Eur Radiol       Date:  2015-09-02       Impact factor: 5.315

Review 7.  Current perspectives on pancreatic serous cystic neoplasms: Diagnosis, management and beyond.

Authors:  Xiao-Peng Zhang; Zhong-Xun Yu; Yu-Pei Zhao; Meng-Hua Dai
Journal:  World J Gastrointest Surg       Date:  2016-03-27

8.  Exendin-4 enhances expression of Neurod1 and Glut2 in insulin-producing cells derived from mouse embryonic stem cells.

Authors:  Qiaoshi Zhao; Yuzhi Yang; Jing Hu; Zhiyan Shan; Yanshuang Wu; Lei Lei
Journal:  Arch Med Sci       Date:  2016-02-02       Impact factor: 3.318

9.  Successful treatment of liver metastasis from solid pseudopapillary tumor of the pancreas: a case report.

Authors:  Taiguo Liu; Jianping He; Dan Cao; Ying Huang
Journal:  Contemp Oncol (Pozn)       Date:  2013-10-07

10.  Middle segment pancreatectomy for a solid serous cystadenoma diagnosed by MRCP and review of the literature: A case report.

Authors:  Yuichiro Okumura; Takehiro Noda; Hidetoshi Eguchi; Yoshifumi Iwagami; Daisaku Yamada; Tadafumi Asaoka; Koichi Kawamoto; Kunihito Gotoh; Shogo Kobayashi; Koji Umeshita; Yasuji Hashimoto; Yutaka Takeda; Masahiro Tanemura; Minoru Shigekawa; Eiichi Morii; Tetsuo Takehara; Masaki Mori; Yuichiro Doki
Journal:  Mol Clin Oncol       Date:  2018-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.